Introductory paragraph
Joubert syndrome is a severe developmental disorder mainly consisting of ataxia, oculomotor apraxia and mental retardation and characterized by cerebellar vermis hypoplasia and a peculiar brainstem malformation known as the "molar tooth sign" 1, 2 . Patients frequently display additional features of cystic kidney disease progressing to renal failure and ocular manifestations including retinopathy, encompassing the Joubert Syndrome Related Disorders (JSRD) group of conditions [3] [4] [5] . We used homozygosity mapping to identify a novel locus on chromosome 12 and subsequently truncating mutations in the centrosomal protein 290 (CEP290) gene in four families and a missense mutation in a fifth family. These families display pleiotropic forms of JSRD with variable retinal and renal manifestations. CEP290 expression was detected in developing murine tissues, most notably in proliferating cerebellar granule neuron populations, and showed centrosome and cilia intracellular localization in non-neuronal cells. Our data imply a direct connection between JSRDs and other cilia/centrosomal human disorders such as isolated nephronophthisis, Senior-Loken, Bardet-Biedl and Meckel syndromes 6, 7 . 4 Joubert syndrome (JS) is an autosomal recessive disorder presenting with psychomotor delay, hypotonia, ataxia, oculomotor apraxia and breathing abnormalities in the neonatal period 1 . Neuroradiologically, JS is characterized by a peculiar malformation of the midbrain-hindbrain junction known as the "molar tooth sign" (MTS), consisting of cerebellar vermis hypo/aplasia, thick and mal-oriented superior cerebellar peduncles and abnormally deep interpeduncular fossa 2 . The MTS has subsequently been reported in a group of syndromes termed "Joubert Syndrome
Related Disorders" (JSRDs), displaying the neurological features of JS associated with involvement of other organs such as the eye and kidney (mainly retinal dystrophy and nephronophthisis). Additional clinical features include optic coloboma, polydactyly, liver fibrosis and other central nervous system malformations [3] [4] . At least eight distinct syndromes sharing the MTS have been described so far. However, their nosologic delineation is still problematic due to the wide phenotypic variability both within and among families 5 . Genetic heterogeneity mirrors clinical heterogeneity of JSRDs, with two genes (AHI1/JBTS3 and NPHP1/JBTS4) and two additional genetic loci (JBTS1 and JBTS2) identified so far [8] [9] [10] [11] [12] [13] . 6, 7 (Fig. 2b) . We identified independent homozygous nucleotide changes in CEP290 in five of the six linked families. Three of these (4732G>T, 5668G>T and 5824C>T) were nonsense mutations resulting in premature truncation of the protein (E1578X, G1890X and Q1942X), and were detected in families from Italy (COR27), Turkey (COR51) and Palestine (MTI133). In family MK05 from Turkey, 6 we identified a 1 bp deletion in exon 28 (3176delT) resulting in a frameshift and generation of a premature stop codon (I1059fsX1064). The fifth mutation (21G>T), identified in Pakistani family COR22, resulted in a nonconservative W7C substitution that affected a highly conserved residue of the protein (Fig. 2c) .
Mutations in the
All mutations segregated with the disease and were not detected in 300 control chromosomes of Italian and Asian origin. In the remaining family consistent for linkage to JBTS5 (MK20), no coding mutations have been identified to date. Either this family harbors mutations in non-coding regions of CEP290 or, alternatively, the disease is due to mutations in a distinct, as yet unidentified, gene.
The phenotype associated with CEP290 mutations is mainly characterized by the neurological features of JS associated with severe retinal and renal involvement.
However the clinical spectrum is broad, including incomplete phenotypes such as cerebello-retinal and cerebello-renal syndromes. Additional features are rare, with one patient with cleft palate and another one with possible liver involvement ( Table 1 and Fig. 3 ). The full-blown JBTS5 phenotype overlaps with Senior-Loken syndrome (SLS), characterized by retinitis pigmentosa plus juvenile nephronophthisis and occasionally associated with neurological involvement and the MTS 4, 5 . Mutations in most nephronophthisis-related genes, encoding ciliary proteins, have been shown to cause SLS, but neurological and neuroradiological features typical of JS were never reported in these patients [19] [20] [21] [22] .
We tested the temporal and regional expression of Cep290 using both RT-PCR and in situ hybridization in mouse brain. A full-length murine Cep290 was assembled from three partially-overlapping cDNA contigs from the human genome browser. The construct encodes a predicted protein that is 89% identical to the full-length human protein on a region syntenic with the human chromosome 12 interval. Northern blot 7 analysis of whole mouse embryo showed roughly equal expression at embryonic day (E) 7-17 ( Fig. 4a) . We found approximately equal expression levels of the Cep290 mRNA in various regions from mouse brain across developmental timepoints using RT-PCR (embryonic day 7 through postnatal day 17), suggesting a possible role for this protein in embryogenesis of several brain structures (data not shown). Cep290
was expressed in multiple organs tested during early postnatal development (P0), with two major transcripts present on Northern blot analysis. Bands of approximately 4.6 and 7.9 kb were detected in roughly equal relative ratios, with the highest levels of expression in the hindbrain, and lower levels in other organs (Fig. 4b) . The 4.6 kb transcript likely corresponds to cDNA clone AK172940, however no 5' stop codon was detected in this clone. The 7.9 kb transcript corresponds to the full length human and mouse Cep290 predicted mRNAs. In situ hybridization analysis of the cerebellum using a ubiquitous cDNA fragment showed the strongest expression in dividing cell populations of the external granule layer (EGL) during development, suggesting a possible role for Cep290 in cell division. The gene was also expressed in the internal granule layer cell population (which derive from the EGL through cell migration) in both development and adulthood (Fig. 4c) . Regions of the telencephalon containing dividing cells also expressed relatively higher levels of Cep290 (data not shown).
Intracellular localization of mouse CEP290 fused to EGFP was examined in both non-ciliated and ciliated cells. A plasmid encoding the constitutive centrosomal protein Centrin 2 fused to DSRedII (CETN2-RFP), which labels the pair of centrioles, was used to stably transfect 293T human non-ciliated kidney cells. These cells were chosen due to the kidney phenotype observed in our patients. GFP-CEP290 localized to the region surrounding the centrioles (i.e. the pericentriolar matrix) in all 8 transfected cells (Fig. 5a) , consistent with the putative centrosomal localization. To test for ciliary localization, we next utilized murine kidney intramedullary collecting duct (IMCD-3) kidney cells that are able to form cilia when grown at confluence.
GFP-CEP290 was found to localize to the base of the cilia, as defined by staining for the pericentriolar matrix protein pericentrin and the stabilized microtubule marker acetylated tubulin (Fig. 5b-c) . A plasmid encoding GFP-CEP290 with the W7C mutation showed localization that was not significantly different from wildtype GFP-CEP290 (data not shown).
The CEP290 product encodes a large protein with a nearly uninterrupted series of coiled-coil domains. The protein has been first identified as 3H11Ag, a tumourassociated antigen defined by the monoclonal antibody 3H11 that specifically recognizes cancer cells in various neoplastic tissues. The cDNA encoding the protein was subsequently cloned from a gastric cancer cell line and the gene mapped to chromosome 12q 23 . Although the protein function was unknown, Northern blot and RT-PCR experiments showed that 3H11Ag mRNA was extensively distributed in embryonic tissue and in different cancerous tissues, but not in corresponding adult tissues, thus suggesting a role for the underlying protein in embryonic development 23 .
Subsequently, 3H11Ag was identified as a centrosomal protein through a massspectrometry based proteomic approach, and named CEP290 24 . Centrosomes are the major microtubule-organizing centers of animal cells. They are involved in the control of ciliary activity and in regulation of cell shape, polarity, motility and cell division through effects on the mitotic spindle 25, 26 .
An increasing number of disorders associated with cystic kidney disease have been linked to mutations in proteins expressed in cilia or centrosomes 7 . These proteins share multiple coiled-coil, SH3 and WD40 modular protein-protein interaction 9 domains. Such proteins may form multimeric complexes in centrosomes and cilia of different tissues, including renal epithelial cells, retinal photoreceptors, cholangiocytes of the bile duct and neuronal axons 6 . Interestingly, the AHI1 gene product also contains several interaction domains, although its subcellular localization to cilia or centrosomal structures has not been tested 8, 9 . These findings provide a unifying frame to understand the pathogenetic mechanism of both isolated renal cystic disorders and distinct pleiotropic syndromes characterized by multiorgan involvement, including JSRDs. Ciliary and centrosomal proteins may interact to respond to extracellular signaling or modulatory cues that are key in maintenance of kidney and retinal homeostasis, and in neuronal development 26, 27 . In particular, defective intraciliary and axonal transport could cause impaired axonal outgrowth possibly responsible for the malformations of the cerebellum and brainstem observed in JSRDs. The identification of CEP290 mutations in patients without renal involvement broadens the phenotypic spectrum associated with disorders of ciliary and centrosomal proteins, and may facilitate the identification of other JSRD genes.
Methods

Patients and families. Eighteen consanguineous families from Europe, the Middle
East, Asia and North America were selected on the basis of the following criteria: 1)
at least one individual with a neuroradiologically proven MTS associated with any JSRD phenotype; 2) exclusion of linkage to known JBTS loci (JBTS1 to 4).
Whenever possible, patients underwent a full diagnostic protocol as previously reported 15 . Parental written informed consent was obtained from all families and the study was approved by the Ethics Committees of UCSD (La Jolla) and CSS-Mendel Institute (Rome). and band intensities for Cep290 were standardized with Gapdh internal controls 8 .
Mouse in situ hybridization. In situ hybridization on frozen mouse brain sections was performed using a non-radioactively digoxigenin-labeled cDNA probe. The
Cep290 probe was amplified from mouse embryonic day 18 (E18) with primers specific to the three longest Cep290 mRNA transcripts (forward 5'-GAATGCTCTAGCCCAAGCAC-3'; reverse 5'-GTGGGCTTCTCCTTCCTTCT-3').
The 739bp probe was cloned into pCR-Blunt II-TOPO vector containing SP6 and T7 promoter priming sites. Antisense cDNA probe transcription was driven from the T7 promoter and transcription of the sense cDNA probe driven from the SP6 promoter.
Mouse brain sections from embryonic through adult timepoints were fixed, and then hybridized using the digoxigenin-labeled cDNA probes overnight at 65°C. Sections were washed, treated with RNAase and washed again before being treated with antidixoxgenin coupled to alkaline phosphatase (Roche). After a further wash in 5M NaCl, 1M Tris base, 1M Tris-Hcl, 2M MgCl2 and 10% Tween-20, the digoxigeninlabeled cDNA probe was detected using NBT and BCIP and sections were stained overnight at room temperature.
Northern-blot analysis. We used the same Cep290 mouse genome sequence to 12 generate the in situ probe for the Northern Blot analysis. The probe was labelled with [α-32P]dCTP using the Prime-It II Random Primer Labeling Kit (Stratagene). A Clontech polyA-selected commercial blot was used to interrogate whole body expression. For specific organ analysis, total RNA was isolated from post-natal day 0 multiple mouse tissues using Trizol and tested for Cep290 expression. After probe hybridization, the blots were developed according to the ExpressHyb Hybridization protocol (Clontech). 4732G>T (36) 5668G>T (41) 5824C>T (42) 21G>T (2) 3176delT (28 Legend: -Absent; + Present; beh-behavior; CB-congenital blindness; CC-cortical cysts; CMD-cortico-medullar differentiation; ELE-elevated liver enzymes; Hyd-hydrocephalus; LE-left eye; micropht-microphtalmus; mo-months; MTS-molar tooth sign; n.a.-not applicable; NPH/UCD-Nephronophthisis / Urine Concentration Defect; ny-nystagmus; OMA-Oculomotor Apraxia; RP-retinitis pigmentosa; US-ultrasound; vr-visus reduction, yrs-years; ?-unknown 
